There was substantial heterogeneity in inclusion criteria, ranging from individuals who were newly diagnosed,13, 28, 29 insulin therapy,26, 30 experiencing severe hypoglycaemia,27 or living with obesity.31 This evidence concerns the gene INS and obesity disorder.